Stocks
CareDx Financial Statements (CDNA) |
||||||||||
| CareDxsmart-lab.ru | % | 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 28.02.2020 | 24.02.2021 | 24.02.2022 | 27.02.2023 | 31.12.2023 | 31.12.2023 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 127.1 | 192.2 | 296.4 | 321.8 | 280.3 | 280.3 | |||
| Operating Income, bln rub | -24.5 | -17.7 | -29.7 | -77.2 | -101.9 | -104.6 | ||||
| EBITDA, bln rub | ? | -24.9 | -16.2 | -29.8 | -77.3 | -82.1 | -89.9 | |||
| Net profit, bln rub | ? | -22.0 | -18.7 | -30.7 | -76.6 | -190.3 | -190.3 | |||
| OCF, bln rub | ? | -2.77 | 33.4 | -19.3 | -25.2 | -18.4 | -18.4 | |||
| CAPEX, bln rub | ? | 3.35 | 10.4 | 20.3 | 24.3 | 9.24 | 9.24 | |||
| FCF, bln rub | ? | -6.12 | 23.1 | -39.6 | -49.6 | -27.6 | -27.6 | |||
| Dividend payout, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| OPEX, bln rub | 106.1 | 146.8 | 228.7 | 286.8 | 277.8 | 281.4 | ||||
| Cost of production, bln rub | 45.5 | 63.1 | 97.4 | 112.2 | 104.5 | 102.6 | ||||
| R&D, bln rub | 30.7 | 48.9 | 76.5 | 90.4 | 81.9 | 81.9 | ||||
| Interest expenses, bln rub | 3.70 | 0.271 | 0.000 | 3.76 | 0.000 | 0.451 | ||||
| Assets, bln rub | 151.7 | 368.5 | 566.6 | 543.0 | 484.6 | 484.6 | ||||
| Net Assets, bln rub | ? | 99.0 | 277.7 | 465.9 | 430.9 | 261.3 | 261.3 | |||
| Debt, bln rub | 3.02 | 16.1 | 17.4 | 39.0 | 34.2 | 34.2 | ||||
| Cash, bln rub | 38.2 | 224.7 | 348.5 | 293.1 | 235.4 | 235.4 | ||||
| Net debt, bln rub | -35.2 | -208.6 | -331.1 | -254.1 | -201.2 | -201.2 | ||||
| Ordinary share price, rub | 21.6 | 72.5 | 45.5 | 11.4 | 12.0 | 5.96 | ||||
| Number of ordinary shares, mln | 42.2 | 46.5 | 52.2 | 53.3 | 53.8 | 53.4 | ||||
| Market cap, bln rub | 909 | 3 368 | 2 376 | 608 | 645 | 318 | ||||
| EV, bln rub | ? | 874 | 3 159 | 2 045 | 354 | 444 | 117 | |||
| Book value, bln rub | 30 | 209 | 379 | 350 | 175 | 175 | ||||
| EPS, rub | ? | -0.52 | -0.40 | -0.59 | -1.44 | -3.54 | -3.56 | |||
| FCF/share, rub | -0.15 | 0.50 | -0.76 | -0.93 | -0.51 | -0.52 | ||||
| BV/share, rub | 0.70 | 4.51 | 7.25 | 6.57 | 3.26 | 3.28 | ||||
| EBITDA margin, % | ? | -19.6% | -8.44% | -10.1% | -24.0% | -29.3% | -32.1% | |||
| Net margin, % | ? | -17.3% | -9.74% | -10.3% | -23.8% | -67.9% | -67.9% | |||
| FCF yield, % | ? | -0.67% | 0.69% | -1.66% | -8.15% | -4.28% | -8.68% | |||
| ROE, % | ? | -22.2% | -6.74% | -6.58% | -17.8% | -72.8% | -72.8% | |||
| ROA, % | ? | -14.5% | -5.08% | -5.41% | -14.1% | -39.3% | -39.3% | |||
| P/E | ? | -41.4 | -180.0 | -77.5 | -7.94 | -3.39 | -1.67 | |||
| P/FCF | -148.6 | 146.0 | -60.1 | -12.3 | -23.4 | -11.5 | ||||
| P/S | ? | 7.16 | 17.5 | 8.02 | 1.89 | 2.30 | 1.14 | |||
| P/BV | ? | 30.7 | 16.1 | 6.27 | 1.74 | 3.68 | 1.82 | |||
| EV/EBITDA | ? | -35.2 | -194.8 | -68.5 | -4.58 | -5.41 | -1.30 | |||
| Debt/EBITDA | 1.42 | 12.9 | 11.1 | 3.29 | 2.45 | 2.24 | ||||
| R&D/CAPEX, % | 917.0% | 472.4% | 377.7% | 371.4% | 886.0% | 886.0% | ||||
| CAPEX/Revenue, % | 2.64% | 5.39% | 6.84% | 7.56% | 3.30% | 3.30% | ||||
| CareDx shareholders | ||||||||||
